PRESS RELEASE published on 01/25/2024 at 13:30, 2 years 2 months ago Caspar.AI Launches Contactless Vitals & Real-time Bed Monitoring Solutions with Arcadia, Shellpoint, and Melur Meadows Caspar.AI, an innovator in AI-driven remote healthcare technology, has launched its Contactless Vitals & Real-Time Bed Monitoring Solutions, revolutionizing remote healthcare with patient-centric models that enable effective extension of services into facilities and home environments. Leveraging proprietary GPTs and LLMs, the solution offers comprehensive health monitoring and proactive real-time alerts, improving patient care and optimizing operational efficiency. Keywords: AI-driven remote healthcare, Contactless Vitals, Real-Time Bed Monitoring, GPTs, LLMs, Patient-Centric Models AI-driven Remote Healthcare Contactless Vitals Real-Time Bed Monitoring GPTs LLMs
Published on 04/09/2026 at 16:00, 46 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 6 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 46 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 16 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 15:40, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/09/2026 at 15:57, 49 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 46 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 44 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 1 minute ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH